Pfizer - 52 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. The latest closing stock price for Pfizer as of February 29, 2024 is 26.56.
  • The all-time high Pfizer stock closing price was 55.87 on December 16, 2021.
  • The Pfizer 52-week high stock price is 42.22, which is 59% above the current share price.
  • The Pfizer 52-week low stock price is 25.76, which is 3% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 34.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 27.7236 29.2823 29.2823 26.5600 26.5600 -6.34%
2023 35.4663 48.2638 48.2638 25.7365 28.3564 -41.22%
2022 46.2067 51.6702 51.7067 38.9749 48.2449 -10.42%
2021 37.8688 32.3014 55.8658 29.7077 53.8592 66.74%
2020 30.0914 31.2734 37.3472 22.9973 32.3014 3.18%
2019 31.3529 33.3242 34.8060 27.0940 31.3054 -6.92%
2018 29.7210 27.1084 35.6203 25.2490 33.6324 24.82%
2017 24.9160 23.6241 27.6738 22.2997 26.9448 15.88%
2016 23.0998 22.0310 26.2222 19.8925 23.2518 4.46%
2015 22.8930 20.9026 24.5325 20.7892 22.2585 7.10%
2014 19.8947 19.6265 21.4096 18.3222 20.7825 5.30%
2013 18.4048 16.1544 20.7476 16.1170 19.7360 26.22%
2012 14.2239 13.1841 16.0859 12.7018 15.6365 20.41%
2011 11.4953 10.1825 13.1001 9.8990 12.9860 28.77%
2010 9.4686 10.4620 11.0534 7.9729 10.0846 0.31%
2009 8.5323 9.5799 10.4178 6.2482 10.0530 8.26%
2008 9.7858 11.2570 11.8319 7.5768 9.2862 -16.85%
2007 12.1300 12.3423 13.2773 10.9573 11.1686 -8.15%
2006 11.8520 10.7616 13.2463 10.3320 12.1592 15.22%
2005 11.3854 11.6136 12.8735 9.3225 10.5534 -10.62%
2004 14.3118 15.2912 16.7106 10.6652 11.8068 -22.31%
2003 13.6024 13.3097 15.4172 12.1154 15.1965 17.76%
2002 14.5939 16.5986 17.5346 10.8555 12.9045 -22.16%
2001 17.2535 18.9965 18.9965 14.7247 16.5778 -12.49%
2000 17.0367 13.0129 20.0948 12.2782 18.9429 43.06%
1999 15.6623 16.6651 20.2897 12.8831 13.2415 -21.50%
1998 13.7318 10.1357 17.0160 9.9013 16.8675 68.94%
1997 7.4974 5.4140 10.4196 5.4140 9.9844 81.93%
1996 4.8052 4.0481 5.9840 3.9505 5.4881 33.96%
1995 3.1127 2.4179 4.3082 2.3740 4.0968 66.69%
1994 2.0480 2.1005 2.5012 1.6689 2.4577 15.31%
1993 1.9579 2.1774 2.2778 1.6354 2.1314 -2.27%
1992 2.2337 2.4776 2.5293 1.9715 2.1810 -11.97%
1991 1.7338 1.1555 2.5293 1.0764 2.4776 112.74%
1990 0.9714 0.9874 1.1754 0.7866 1.1646 20.50%
1989 0.8606 0.7752 1.0396 0.7337 0.9665 24.15%
1988 0.7090 0.6282 0.7902 0.6282 0.7785 29.21%
1987 0.8416 0.7943 0.9800 0.5379 0.6025 -22.90%
1986 0.7720 0.6406 0.9320 0.6021 0.7815 20.49%
1985 0.5923 0.5172 0.7142 0.4884 0.6486 19.82%
1984 0.4571 0.4629 0.5413 0.3843 0.5413 18.19%
1983 0.4937 0.4340 0.5733 0.4340 0.4580 3.81%
1982 0.3871 0.3363 0.5108 0.3219 0.4412 29.35%
1981 0.3152 0.3411 0.3507 0.2610 0.3411 0.00%
1980 0.2661 0.2402 0.3411 0.2090 0.3411 35.25%
1979 0.2136 0.2122 0.2610 0.1874 0.2522 18.85%
1978 0.2035 0.1753 0.2458 0.1633 0.2122 21.05%
1977 0.1712 0.1842 0.1842 0.1505 0.1753 -6.46%
1976 0.1809 0.1818 0.2002 0.1633 0.1874 4.93%
1975 0.1914 0.2057 0.2338 0.1537 0.1786 -14.55%
1974 0.2124 0.2770 0.2826 0.1385 0.2090 -24.55%
1973 0.2811 0.2794 0.3355 0.2490 0.2770 0.84%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $152.689B $58.496B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $719.883B 119.88
Novo Nordisk (NVO) Denmark $545.415B 44.93
Johnson & Johnson (JNJ) United States $389.136B 15.49
Merck (MRK) United States $324.660B 85.46
AbbVie (ABBV) United States $314.432B 16.02
Novartis AG (NVS) Switzerland $216.666B 15.01
AstraZeneca (AZN) United Kingdom $202.610B 17.95
Sanofi (SNY) $121.420B 10.93
Innoviva (INVA) United States $0.984B 8.87